How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages
How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether […]
